9 METERS BIOPHARMA, INC. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
9 Meters Biopharma, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2015 to Q1 2023.
  • 9 Meters Biopharma, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2023 was -$226M, a 25.7% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.